(Date:1/8/2009)...enator Daschle at his confirmation hearing to be t... , , WASHINGTON, Jan. 8 /PRNewswire-USNewswire/...member Senator Tom Daschle, nominee for Department...duced by fellow BPC founder and friend Senator Bob...ng was convened by the Senate Health, Education, L...
(Date:1/8/2009)... could shape new treatments for secondary pneumoni...wire/ -- Scientists at St. Jude Children,s Researc...tment for bacterial pneumonia following influenza....zithromycin, which kill bacteria by inhibiting the...andard first-line treatment with the "beta-lactam"...
(Date:1/8/2009)...olution Key Factor in Decision for Florida Multi-S...Jan. 8 Allscripts announ...e largest multi-specialty group practices in the S...s Enterprise(TM) Electronic Health Record (EHR) to...fices across Central Florida. , , (Logo: htt...
(Date:1/8/2009)...hurtful comments, study suggests , , TH...restimate how strongly they would react to racist ... percent of study participants at York University,...ent with a white person rather than a black one, e...out the black person when he left the room. , ...
Breaking Medicine News(10 mins):Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Many Turn Blind Eye to Racism 2...ted by Fay Guarraci, an assistance professor of ps...e student revealed that moderate doses // of caffe...f female rats. This study is one of the kinds and...ffects of caffeine on the sexual stimulation of th...
... Minister Tony Abbott told the press that all the ...ered by medicare if they consulted qualified healt...inly to ensure proper medical care in the rural ar...ths this plan will add $5 million to the annual ex...
...ves hundreds of lives ever year. The need the orga...ter organ // . Of all the organ transplantations ... the bad news is that there is a sudden fall in th...onate organs especially kidneys. Due to this the ...
...m in London has found a unique way to help people ...serving people the much-needed dose of light // . ...nts to counter the effect of dark winter days. Up... of them women, are believed to suffer from SAD - ...
Other Medicine News:(Date:1/8/2009)...ney transplantation to be Quark,s second indicatio...iRNA product candidate , , FREMONT, Calif., Ja...a development-stage pharmaceutical company discove...based therapeutics, today announced that it has in...trial evaluating its systemically administered siR...
(Date:1/8/2009)...Southwestern to Identify and Validate Novel Gene E...h Innovative Gene Expression Platform , , FREMO...Gen Biosystems, Inc. (OTC Bulletin Board: WGBS), a...sion, genotyping, cell biology and stem cell resea...arch collaboration with the University of Texas S...
(Date:1/8/2009)... CHICAGO, Jan. 8 If you are taking...y, you,re not alone. Half of the people taking,pr...he reasons are,varied -- they forget, are busy wi... not to. Noncompliance has been called the Achille...neral Everett Koop commented, "Drugs don,t,work i...
(Date:1/8/2009)...BRIDGE, Mass. and COLUMBUS, Ohio, Jan. 8 /PRNewswi...of proprietary nucleic acid assays, today announce...BK Viral Quantitative Assay are complete. , , ...tion, linearity, specificity and reproducibility a...ere determined. The data obtain agreed with intern...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Best Week Ever for Nothing But Nets 762 1Best Week Ever for Nothing But Nets 762 2Best Week Ever for Nothing But Nets 762 3FDA Approves the Opening of a Phase II Registration Protocol Using REXIN G 28R 29 for Osteosarcoma in California U S A 5583 1FDA Approves the Opening of a Phase II Registration Protocol Using REXIN G 28R 29 for Osteosarcoma in California U S A 5583 2FDA Approves the Opening of a Phase II Registration Protocol Using REXIN G 28R 29 for Osteosarcoma in California U S A 5583 3Scientists warn that species extinction could reduce productivity of plants on Earth by half 1117 1Scientists warn that species extinction could reduce productivity of plants on Earth by half 1117 2GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 5579 1GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 5579 2... significant additional protection against,infecti...cervical,cancer candidate vaccine, PHILADELPHIA, J...m an interim analysis of a Phase III study show th...r candidate vaccine,provides up to 100 percent pr...sed by the most common types of human papillomavir...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: